GLI1 and acute myeloid leukemia: Using GLI Reporter cell lines, we could show that an active GLI signaling cascade in AML cells is mainly SMO-independent as the treatment with the SMO inhibitor cyclopamine had hardly any impact on the GLI promoter activity of all six analyzed AML cell lines.